{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:16:28Z","timestamp":1764936988513,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Fundaci\u00f3n Te\u00f3filo Hernando"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bmc.2018.04.019","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T12:32:40Z","timestamp":1523277160000},"page":"2551-2560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca2+ overload, as a multitarget strategy for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Dorleta","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel L.","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Viejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Lajarin-Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristobal","family":"de los Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.04.019_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2018.04.019_b0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bmc.2018.04.019_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.bmc.2018.04.019_b0020","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2018.04.019_b0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005072-199409000-00003","article-title":"Alzheimer's disease: a central role for amyloid","volume":"53","author":"Selkoe","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bmc.2018.04.019_b0030","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.clinthera.2015.05.510","article-title":"Current practices in the treatment of Alzheimer\u2019s disease: where is the evidence after the phase III trials?","volume":"37","author":"Ehret","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.bmc.2018.04.019_b0035","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschemneuro.7b00270","article-title":"Classics in chemical neuroscience: memantine","volume":"8","author":"Alam","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0040","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer's disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/acs.jmedchem.7b00393","article-title":"BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer's disease","volume":"61","author":"Prati","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bmc.2016.11.032","article-title":"N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: potential multifunctional anti-Alzheimer's agents","volume":"25","author":"Kosak","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2015.02.016","article-title":"Benzothiazepine CGP37157 and its 2'-isopropyl analogue modulate Ca(2)(+) entry through CALHM1","volume":"95","author":"Moreno-Ortega","year":"2015","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.bmc.2018.04.019_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmech.2015.12.043","article-title":"Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na+\/Ca2+ exchanger","volume":"109","author":"Martinez-Sanz","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0065","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1021\/acs.jmedchem.6b00478","article-title":"Gramine derivatives targeting Ca2+ channels and Ser\/Thr phosphatases: a new dual strategy for the treatment of neurodegenerative diseases","volume":"59","author":"Lajar\u00edn-Cuesta","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0070","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.019_b0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00424-009-0736-1","article-title":"Calcium hypothesis of Alzheimer's disease","volume":"459","author":"Berridge","year":"2010","journal-title":"Pfl\u00fcgers Arch"},{"key":"10.1016\/j.bmc.2018.04.019_b0080","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mcn.2017.07.002","article-title":"Downregulation of protein phosphatase 2A by Apolipoprotein E: Implications for Alzheimer's disease","volume":"83","author":"Theendakara","year":"2017","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0090","doi-asserted-by":"crossref","first-page":"27677","DOI":"10.1074\/jbc.M114.565358","article-title":"Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau","volume":"289","author":"Arif","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0095","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jnen\/63.10.1080","article-title":"Downregulation of protein phosphatase 2A carboxymethylation and methyltransferase may contribute to Alzheimer\u2019s disease pathogenesis","volume":"63","author":"Sontag","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bmc.2018.04.019_b0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4155\/fmc.11.47","article-title":"Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease","volume":"3","author":"Voronkov","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2018.04.019_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1517\/13543776.2016.1135903","article-title":"Ligands for Ser\/Thr phosphoprotein phosphatases: a patent review (2005\u20132015)","volume":"26","author":"Lajarin-Cuesta","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2018.04.019_b0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/CAD.0000000000000358","article-title":"A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia","volume":"27","author":"Enjeti","year":"2016","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bmc.2018.04.019_b0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-160544","article-title":"A phase IIa randomized control trial of VEL015 (sodium selenate) in mild-moderate Alzheimer's disease","volume":"54","author":"Malpas","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bmc.2018.04.019_b0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1021\/cn300009e","article-title":"Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry","volume":"3","author":"Gonzalez-Lafuente","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(01)01476-5","article-title":"Novel marine-derived halogen-containing gramine analogues induce vasorelaxation in isolated rat aorta","volume":"432","author":"Iwata","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.019_b0130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0135","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1139\/y87-168","article-title":"Ionic changes induced by excitatory amino acids in the rat cerebral cortex","volume":"65","author":"Pumain","year":"1987","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.019_b0140","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1460-9568.1994.tb00588.x","article-title":"Calcium channel currents in undifferentiated human neuroblastoma SH-SY5Y cells: actions and possible interactions of dihydropyridines and omega-conotoxin","volume":"6","author":"Reeve","year":"1994","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0145","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1476-5381.1994.tb14831.x","article-title":"Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome","volume":"111","author":"Shuker","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2018.04.019_b0150","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1523\/JNEUROSCI.21-20-07985.2001","article-title":"An NMDA receptor signaling complex with protein phosphatase 2A","volume":"21","author":"Chan","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuro.2013.05.002","article-title":"Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology","volume":"37","author":"Kamat","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bmc.2018.04.019_b0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cbi.2005.12.001","article-title":"Effects of microcystins over short- and long-term memory and oxidative stress generation in hippocampus of rats","volume":"159","author":"Maidana","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2018.04.019_b0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2004.03.037","article-title":"Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit","volume":"126","author":"Tian","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2018.04.019_b0170","unstructured":"http:\/\/toxnet.nlm.nih.gov\/cgi-bin\/sis\/search2\/r?dbs+hsdb:@term+@DOCNO+7243, Hazardous Substance Data Bank (HSDB). Health & Human Services: Toxnet, Toxicology Data Network, 2005."},{"key":"10.1016\/j.bmc.2018.04.019_b0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijdevneu.2006.08.005","article-title":"Altered levels of PP2A regulatory B\/PR55 isoforms indicate role in neuronal differentiation","volume":"24","author":"Schild","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.bmc.2018.04.019_b0180","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.febslet.2006.06.021","article-title":"Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by memantine","volume":"580","author":"Chohan","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2018.04.019_b0185","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2006.09.025","article-title":"Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins","volume":"127","author":"Xing","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2018.04.019_b0190","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj2840539","article-title":"Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship","volume":"284","author":"Takai","year":"1992","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2018.04.019_b0195","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0960-894X(01)00026-9","article-title":"Importance of the C28\u2013C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2A","volume":"11","author":"Frydrychowski","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.04.019_b0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cbic.200301023","article-title":"Fluorine in medicinal chemistry","volume":"5","author":"Bohm","year":"2004","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmc.2018.04.019_b0205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbr.2011.09.035","article-title":"Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia","volume":"226","author":"Costa","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bmc.2018.04.019_b0210","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2008.05805.x","article-title":"Mechanism of okadaic acid-induced neuronal death and the effect of estrogens","volume":"108","author":"Yi","year":"2009","journal-title":"J Neurochem."},{"key":"10.1016\/j.bmc.2018.04.019_b0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2013.01.075","article-title":"Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor","volume":"238","author":"Kamat","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2018.04.019_b0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.10.064","article-title":"Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity","volume":"1309","author":"Kamat","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.bmc.2018.04.019_b0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pbb.2011.08.019","article-title":"Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain","volume":"100","author":"Kamat","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bmc.2018.04.019_b0230","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.toxicon.2011.03.005","article-title":"Induction of oxidative DNA damage by the marine toxin okadaic acid depends on human cell type","volume":"57","author":"Valdiglesias","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2018.04.019_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0169-328X(03)00294-8","article-title":"Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel","volume":"117","author":"Ekinci","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bmc.2018.04.019_b0240","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/cmdc.201700037","article-title":"Rodr\u00edguez-Franco MI, de los R\u00edos C, Santos MM. Optimization of bicyclic lactam derivatives as NMDA receptor antagonists","volume":"12","author":"Espadinha","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2018.04.019_b0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J Immunol Methods"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618301962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618301962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:54:55Z","timestamp":1760835295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618301962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0968089618301962"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.04.019","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca2+ overload, as a multitarget strategy for the treatment of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}